Long-term risk factor control after a cardiac rehabilitation programme

Lorelle V Toms1, Maureen E O'Neill, Anne Gardner

  • 1Cardiac Rehabilitation, The Canberra Hospital, ACT.

Insights

Participants in Phase II cardiac rehabilitation (CRP) showed better long-term control of some cardiac risk factors compared to non-participants (NP) post myocardial infarction (MI). However, health perception and return to work rates were similar between groups.

Area of Science:

  • Cardiology
  • Public Health
  • Rehabilitation Medicine

Background:

  • Myocardial infarction (MI) survivors require long-term management of cardiovascular risk factors.
  • Cardiac rehabilitation (CR) programs aim to improve patient outcomes and reduce future cardiac events.
  • Understanding the long-term benefits of CR beyond the initial program is crucial for patient care.

Purpose of the Study:

  • To compare long-term (18-36 months post-MI) risk factor control, self-rated health, and return to work rates between Phase II cardiac rehabilitation participants (CRP) and non-participants (NP).
  • To evaluate the effectiveness of a Phase II CR program in Australia on sustained patient outcomes.

Main Methods:

  • A comparative study was conducted involving participants and non-participants of a Phase II cardiac rehabilitation program.
  • Data on total cholesterol, exercise habits, blood pressure control, self-rated health perception, and return to work were collected and analyzed.
  • Statistical analysis was performed to determine significant differences between the CRP and NP groups.

Main Results:

  • CRP demonstrated significantly better long-term control for total cholesterol levels (TC < = 6.5 mmol/L) compared to NP (7% vs. 28%, p = 0.006).
  • CRP were more likely to engage in regular exercise (79% vs. 61%, p = 0.038).
  • No significant differences were observed between CRP and NP in achieving blood pressure targets, return to work rates, or self-rated health perception.

Conclusions:

  • Phase II cardiac rehabilitation participants exhibited superior long-term management of specific cardiovascular risk factors, notably cholesterol levels and exercise adherence, compared to non-participants.
  • While CR improved certain risk factor controls, its impact on blood pressure, return to work, and perceived health was comparable between participants and non-participants.
  • The study highlights the value of CR in promoting sustained risk factor modification and provides a basis for ongoing outcome assessments in Australian CR programs.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...